Skip to Main Content

Advertisement

Skip Nav Destination

Antibody Reengineering Improves Therapeutic Index in Preclinical Models

Cancer Discov (2013) 3 (12): 1326.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal